Clin2
NCT07779252Possibly a fitRecruiting

Study of a new treatment for frown lines between the eyebrows

Moderate to Severe Glabellar Lines

Part of Skin clinical trials.

This study tests a new medication (IPN10200) to safely reduce moderate to severe frown lines between the eyebrows in adults. It may help if you are bothered by these lines and are looking for a non-surgical option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
160 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • Your frown lines between the eyebrows are moderate to severe (grade 2 or 3).
  • You are dissatisfied or very dissatisfied with these lines.
  • You have not had Botox or similar injections in any part of your body for at least 9 months.
  • You do not have any active skin infections or recent surgeries in the upper face area.
  • You are willing to follow the study rules and use birth control if you are a woman who can become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06937944Recruiting· Phase 3
New Botox-like injection for frown lines

This study tests a new botulinum toxin injection (similar to Botox) to see how well it smooths moderate to severe frown lines between the eyebrows. The treatment is given as a single injection and may help soften those lines for several months.

Beijing, Beijing Municipality
NCT07756580Recruiting· Phase 1
Study of injections for frown lines between the eyebrows

This study tests two different injection treatments for moderate to severe frown lines between the eyebrows. It aims to find the best way to use these treatments to improve your appearance.

Glendale, Arizona
NCT06205797Recruiting· Phase 3
Study of a new treatment for frown lines between the eyebrows

This trial tests an injection called HU-045 to reduce moderate to severe frown lines. It may help adults who want to soften those vertical lines between the eyebrows.

Seoul
NCT07870694Recruiting· Phase 3
Injectable treatment for frown lines between the eyebrows

This study tests a new injectable medicine for moderate to severe frown lines between the eyebrows (the '11' lines). It aims to see if the treatment is safe and effective at smoothing these wrinkles.

Seoul
NCT07871513Recruiting· Phase 2
Facial line treatment with two botulinum toxins

This study tests a new combination of two botulinum toxin types (trenibotulinumtoxinE and onabotulinumtoxinA, commonly known as Botox) for treating moderate to severe frown lines between the eyebrows. It aims to see if the combination is safe and works well.

Glendale, Arizona
NCT07013279Not yet recruiting· Phase 3
Treatment for moderate to severe frown lines

This study tests a new treatment for moderate to severe frown lines between the eyebrows. It aims to see if the treatment is safe and effective for reducing the appearance of these lines.

Seoul

Hear when a new Moderate to Severe Glabellar Lines trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.